Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial
A. C. Hoffman(University of Southern California), Anders Hartmann(Oslo University Hospital), Thomas Gauler, Michael Stöckle(Saarland University), Kathleen D. Danenberg(University of Southern California), Simone Bertz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jens Lehmann(Universität Innsbruck), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter J. Wild(Goethe University Frankfurt), P. V. Danenberg(University of Southern California), Christina Leicht(University Hospital Regensburg)
Cited by 1
Related Papers
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411